Skip to content

Ethyl Chloride Spray Versus Subcutaneous Lidocaine Anaesthetic Prior to Contraceptive Implant Insertion

Study Looking at Acceptability of Using Ethyl Chloride Spray Versus Subcutaneous Lidocaine Anaesthetic Prior to Contraceptive Implant Insertion

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02651207
Enrollment
0
Registered
2016-01-08
Start date
2016-11-30
Completion date
2016-11-30
Last updated
2017-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Brief summary

Study to look at the acceptability of local anaesthetic spray versus injection, prior to contraceptive implant insertion

Detailed description

Currently, patients undergoing contraceptive implant insertion are offered local anaesthetic with an injection before insertion. This study aims to look at whether patients find using the local anaesthetic spray more acceptable or equally acceptable to using local anaesthetic injection. Both are currently licensed products for use as skin anaesthesia but the spray is potentially quicker and involves less injections. Some areas of sexual health are already offering this option but there isn't much evidence as to which patients find more acceptable. Patients in this study will be given a choice of anaesthetic asked to complete a short questionnaire, giving a pain score , on the pain rating scale of 0 to 10, ( being no pain to 10 being extremely painful. ) In addition, they will be asked to give the reasons for their choice. The questionnaire will be anonymous. Average pain scores will be calculated between in group and compared.

Interventions

OTHERQuestionnaire based study looking at pain scores felt by patients either having a lidocaine injection or ethyl chloride spray prior to insertion of a contraceptive implant

Sponsors

Tayside Medical Science Centre
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
13 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Patient has chosen to use the implant as a method of contraception * Patients will be assessed for medical eligibility for the contraceptive implant have no contraindications to either the implant, lidocaine or the ethyl chloride spray. However, if they have a known sensitivity to either the spray or the lidocaine ejection, they will be offered the other. * Age between 13 and 55 * Has capacity to consent * Has read the information sheet and consents to the study * This will be offered for insertions of implant only i.e. not implant removals

Exclusion criteria

* Has a contraindication to have a contraceptive implant * Doesn't wish to have a implant * Allergy to either the implant, the lidocaine, the ethyl chloride or any of the incipient ingredients. Although patients will be given the option, if they have an allergy/contraindication to one of the products, they will be offered the other * Is under 13 or over 55

Design outcomes

Primary

MeasureTime frameDescription
acceptability of using ethyl chloride spray versus subcutaneous lidocaine anaesthetic prior to contraceptive implant insertionone yearQuestionnaire based study looking at pain scores on the numeric pain rating scale 0 to 10, 0 being no pain to 10 being extremely painful

Secondary

MeasureTime frameDescription
acceptability of using ethyl chloride spray versus subcutaneous lidocaine anaesthetic prior to contraceptive implant insertionone yearQuestionnaire looking at the reasons why women chose to use the injection or the spray

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026